04460041 Adec 463b Ba9d 6a12038ab672 01
Palonosetron Hydrochloride Injection
Product Images NDC 69097-927
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Palonosetron Hydrochloride (NDC 69097-927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
04460041 Adec 463b Ba9d 6a12038ab672 02
This is a product description for an intravenous injection containing palonosetron hydrochloride, used to prevent nausea and vomiting caused by chemotherapy treatment. Each milliliter of aqueous solution contains 0.05 mg of palonosetron hydrochloride, along with other ingredients. The medication is available as a single-use sterile vial, and should be discarded if not fully used. It is manufactured and distributed by Cipla USA, Inc. and dispensed only with a prescription. Storage suggestions are provided, along with instructions for use.*
04460041 Adec 463b Ba9d 6a12038ab672 03
This is a description of Palonosetron HCl Injection, which is a medication that must be stored at a temperature between 20°C and 25°C (68°F-77°F). The product is produced by Cipla and comes in a 5 mL single-use sterile vial that is for intravenous injection only. The label includes a Lot number ("4 LOT"), an expiration date ("EXP"), an NDC number ("69097-927-35"), and a warning to protect it from light. The address of Cipla is provided as well.*
0fcdf305 66bd 4fe0 Bbc2 8340f7d6894b 258 2
0fcdf305 66bd 4fe0 Bbc2 8340f7d6894b 291 2
0fcdf305 66bd 4fe0 Bbc2 8340f7d6894b 293 2
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
